APNEA 是腺苷 A3 受体的非选择性激动剂。

APNEA is a non-selective agonist of adenosine A3 receptor.

APNEA at the subprotective dose of 1 mg/kg against electroconvulsions, significantly potentiated the anticonvulsive action of phenobarbital, diphenylhydantoin and valproate against maximal electroshock, being ineffective at lower doses[2].

APNEA (0.0039-1 mg/kg) enhanced the protective activity of carbamazepine. APNEA (0.0156 and 1 mg/kg) administered alone or in combination with carbamazepine significantly decreased the body temperature and impaired long-term memory[2].

89705-21-5

C18H22N6O4

386.41

N6-[2-(4-氨基苯基)乙基]腺嘌呤;(2R,3R,4S,5R)-2-[6-[2-(4-aminophenyl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

DMSO:200 mg/mL (517.58 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years